Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521306) titled 'Biomarkers for Predicting Mortality in Patients With Suspected Sepsis' on April 3.
Study Type: Observational
Primary Sponsor: Antalya Training and Research Hospital
Condition:
Sepsis
Mortality
Biomarkers
Recruitment Status: Not recruiting
Date of First Enrollment: May 1, 2023
Target Sample Size: 250
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07521306
Published by HT Digital Content Services with permission from Health Daily Digest....